Work

Triple-negative breast cancer: current perspective on the evolving therapeutic landscape

Year: 2019
Type: article
Abstract: Triple-negative breast cancer (TNBC) is known to have a poor prognosis and limited treatment options, namely chemotherapy. Different molecular studies have recently classified TNBC into different subtypes opening the door to potential new-targeted treatment options. In this review, we discuss the current standard of care in the treatment of TNBC in the neoadjuvant, adjuvant and metastatic settings. In addition, we summarize the ongoing phase III clinical trials evaluating different associations between the 3 pillars of anticancer treatment: chemotherapy, targeted therapy and immunotherapy.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W2966623267
FWCI: 7.735
Cites: 43
Cited by: 202
Related to: 10